BioNTech SE Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by BioNTech SE on January 28, 2026, covering the month of January 2026. The filing serves to disclose a material corporate governance event regarding the appointment of a new executive to the Management Board.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a personnel appointment and does not contain financial performance data.
Material Changes
The primary material change disclosed is the appointment of Kylie Jimenez to the Management Board as Chief People Officer (CPO), effective March 1, 2026. This decision was made by the Supervisory Board.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on business performance, or discussion of risks and contingencies. The document focuses solely on the executive appointment.
Key Facts for Investors to Verify
- Kylie Jimenez has been appointed as Chief People Officer (CPO).
- The appointment is effective March 1, 2026.
- The appointment was approved by the Supervisory Board.
- The full press release is attached as Exhibit 99.1.